GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
56 hedge funds and large institutions have $9.81M invested in Genocea Biosciences, Inc. in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Holders
56
Holding in Top 10
1
Calls
$17K
Puts
–
Top Buyers
| 1 | +$199K | |
| 2 | +$145K | |
| 3 | +$128K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$46.4K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$28.7K |
Top Sellers
| 1 | -$844K | |
| 2 | -$715K | |
| 3 | -$488K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$220K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$142K |